"The concept of paying for value in the cancer care space has gained steam of late with health insurers, as major companies including Anthem, UnitedHealth, Aetna and Highmark have all debuted value-based oncology payment models aimed at reducing costs and improving quality. And when it comes to paying for all types of drugs, insurers are increasingly pushing manufacturers toward outcomes-based pricing deals."  MORE >>